CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
Conditions
Gastric Cancer · Colon Cancer · Rectal Cancer · Esophageal Cancer · Pancreas Cancer · Lung Cancer · Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Shanxi Bethune Hospital, Taiyuan, Shanxi, China
Shanxi Bethune Hospital, Taiyuan, Shanxi, China
Shanxi Bethune Hospital, Taiyuan, Shanxi, China
Study leads
Qi Mei, M.D
Principal Investigator
Shanxi Bethune Hospital/Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology
Shuang Wei, M.D
Principal Investigator
Shanxi Bethune Hospital/Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology
Jia Wei, M.D
Principal Investigator
Shanxi Bethune Hospital/Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology